|
1
|
Storz P: Reactive oxygen species in tumor
progression. Front Biosci. 10:1881–1896. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liou GY and Storz P: Reactive oxygen
species in cancer. Free Radic Res. 44:479–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schieber M and Chandel NS: ROS function in
redox signaling and oxidative stress. Curr Biol. 24:R453–R462.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mittler R: ROS Are Good. Trends Plant Sci.
22:11–19. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Di Meo S, Reed TT, Venditti P and Victor
VM: Harmful and beneficial role of ROS. Oxid Med Cell Longev.
2016:79091862016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu WS: The signaling mechanism of ROS in
tumor progression. Cancer Metastasis Rev. 25:695–705. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
de Sá, Junior PL, Câmara DAD, Porcacchia
AS, Fonseca PMM, Jorge SD, Araldi RP and Ferreira AK: The roles of
ROS in cancer heterogeneity and therapy. Oxid Med Cell Longev.
2017:24679402017.PubMed/NCBI
|
|
8
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS
release. Physiol Rev. 94:909–950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han D, Williams E and Cadenas E:
Mitochondrial respiratory chain-dependent generation of superoxide
anion and its release into the intermembrane space. Biochem J.
353:411–416. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Burdon RH: Superoxide and hydrogen
peroxide in relation to mammalian cell proliferation. Free Radic
Biol Med. 18:775–794. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cannito S, Novo E, di Bonzo LV, Busletta
C, Colombatto S and Parola M: Epithelial-mesenchymal transition:
from molecular mechanisms, redox regulation to implications in
human health and disease. Antioxid Redox Signal. 12:1383–1430.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pani G, Giannoni E, Galeotti T and
Chiarugi P: Redox-based escape mechanism from death: the cancer
lesson. Antioxid Redox Signal. 11:2791–2806. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cichon MA and Radisky DC: ROS-induced
epithelial-mesenchymal transition in mammary epithelial cells is
mediated by NF-kB-dependent activation of Snail. Oncotarget.
5:2827–2838. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lim SO, Gu JM, Kim MS, Kim HS, Park YN,
Park CK, Cho JW, Park YM and Jung G: Epigenetic changes induced by
reactive oxygen species in hepatocellular carcinoma: methylation of
the E-cadherin promoter. Gastroenterology. 135:2128–2140, 2140
e2121-2128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: an alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Shi J, Chai K, Ying X and Zhou BP:
The role of snail in EMT and tumorigenesis. Curr Cancer Drug
Targets. 13:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
De Craene B, Denecker G, Vermassen P,
Taminau J, Mauch C, Derore A, Jonkers J, Fuchs E and Berx G:
Epidermal snail expression drives skin cancer initiation and
progression through enhanced cytoprotection, epidermal
stem/progenitor cell expansion and enhanced metastatic potential.
Cell Death Differ. 21:310–320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee SY, Jeon HM, Ju MK, Kim CH, Yoon G,
Han SI, Park HG and Kang HS: Wnt/Snail signaling regulates
cytochrome C oxidase and glucose metabolism. Cancer Res.
72:3607–3617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hsu PP and Sabatini DM: Cancer cell
metabolism: Warburg and beyond. Cell. 134:703–707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vander Heiden MG, Cantley LC and Thompson
CB: Understanding the Warburg effect: the metabolic requirements of
cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Finley LW, Zhang J, Ye J, Ward PS and
Thompson CB: SnapShot: cancer metabolism pathways. Cell Metab.
17:466, e462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee SY, Jeon HM, Ju MK, Jeong EK, Kim CH,
Yoo MA, Park HG, Han SI and Kang HS: Dlx-2 is implicated in TGF-β-
and Wnt-induced epithelial-mesenchymal, glycolytic switch, and
mitochondrial repression by Snail activation. Int J Oncol.
46:1768–1780. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee SY, Jeon HM, Ju MK, Jeong EK, Kim CH,
Park HG, Han SI and Kang HS: Dlx-2 and glutaminase upregulate
epithelial-mesenchymal transition and glycolytic switch.
Oncotarget. 7:7925–7939. 2016.PubMed/NCBI
|
|
31
|
Merlo GR, Zerega B, Paleari L, Trombino S,
Mantero S and Levi G: Multiple functions of Dlx genes. Int J Dev
Biol. 44:619–626. 2000.PubMed/NCBI
|
|
32
|
Panganiban G and Rubenstein JL:
Developmental functions of the Distal-less/Dlx homeobox genes.
Development. 129:4371–4386. 2002.PubMed/NCBI
|
|
33
|
Lee SY, Jeon HM, Kim CH, Ju MK, Bae HS,
Park HG, Lim SC, Han SI and Kang HS: Homeobox gene Dlx-2 is
implicated in metabolic stress-induced necrosis. Mol Cancer.
10:1132011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yilmaz M, Maass D, Tiwari N, Waldmeier L,
Schmidt P, Lehembre F and Christofori G: Transcription factor Dlx2
protects from TGFβ-induced cell-cycle arrest and apoptosis. EMBO J.
30:4489–4499. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tang P, Huang H, Chang J, Zhao GF, Lu ML
and Wang Y: Increased expression of DLX2 correlates with advanced
stage of gastric adenocarcinoma. World J Gastroenterol.
19:2697–2703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yan ZH, Bao ZS, Yan W, Liu YW, Zhang CB,
Wang HJ, Feng Y, Wang YZ, Zhang W, You G, et al: Upregulation of
DLX2 confers a poor prognosis in glioblastoma patients by inducing
a proliferative phenotype. Curr Mol Med. 13:438–445. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim CH, Jeon HM, Lee SY, Ju MK, Moon JY,
Park HG, Yoo MA, Choi BT, Yook JI, Lim SC, et al: Implication of
snail in metabolic stress-induced necrosis. PLoS One. 6:e180002011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoon YS, Lee JH, Hwang SC, Choi KS and
Yoon G: TGF beta1 induces prolonged mitochondrial ROS generation
through decreased complex IV activity with senescent arrest in
Mv1Lu cells. Oncogene. 24:1895–1903. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sariban-Sohraby S, Magrath IT and Balaban
RS: Comparison of energy metabolism in human normal and neoplastic
(Burkitt's lymphoma) lymphoid cells. Cancer Res. 43:4662–4664.
1983.PubMed/NCBI
|
|
40
|
Dong C, Yuan T, Wu Y, Wang Y, Fan TW,
Miriyala S, Lin Y, Yao J, Shi J, Kang T, et al: Loss of FBP1 by
Snail-mediated repression provides metabolic advantages in
basal-like breast cancer. Cancer Cell. 23:316–331. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jin L, Zhu C, Wang X, Li C, Cao C, Yuan J
and Li S: Urocortin attenuates TGFβ1-induced Snail1 and slug
expressions: inhibitory role of Smad7 in Smad2/3 signaling in
breast cancer cells. J Cell Biochem. 116:2494–2503. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rios Garcia M, Steinbauer B, Srivastava K,
Singhal M, Mattijssen F, Maida A, Christian S, Hess-Stumpp H,
Augustin HG, et al: Acetyl-CoA carboxylase 1-dependent protein
acetylation controls breast cancer metastasis and recurrence. Cell
Metab. 26:842–855, e845. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu H, Tian Y, Yuan X, Wu H, Liu Q, Pestell
RG and Wu K: The role of CD44 in epithelial-mesenchymal transition
and cancer development. Onco Targets Ther. 8:3783–3792.
2015.PubMed/NCBI
|
|
44
|
Chanmee T, Ontong P, Kimata K and Itano N:
Key roles of hyaluronan and Its CD44 receptor in the stemness and
survival of cancer stem cells. Front Oncol. 5:1802015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Han X, Aslanian A and Yates JR III: Mass
spectrometry for proteomics. Curr Opin Chem Biol. 12:483–490. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dettmer K, Aronov PA and Hammock BD: Mass
spectrometry-based metabolomics. Mass Spectrom Rev. 26:51–78. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Min C, Eddy SF, Sherr DH and Sonenshein
GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J
Cell Biochem. 104:733–744. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Taniguchi K and Karin M: NF-κB,
inflammation, immunity and cancer: Coming of age. Nat Rev Immunol.
18:309–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pires BR, Mencalha AL, Ferreira GM, de
Souza WF, Morgado-Díaz JA, Maia AM, Corrêa S and Abdelhay ES:
NF-kappaB is involved in the regulation of EMT genes in breast
cancer cells. PLoS One. 12:e01696222017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Huang S, Pettaway CA, Uehara H, Bucana CD
and Fidler IJ: Blockade of NF-kappaB activity in human prostate
cancer cells is associated with suppression of angiogenesis,
invasion, and metastasis. Oncogene. 20:4188–4197. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tobar N, Villar V and Santibanez JF:
ROS-NFkappaB mediates TGF-beta1-induced expression of
urokinase-type plasminogen activator, matrix metalloproteinase-9
and cell invasion. Mol Cell Biochem. 340:195–202. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kang KA, Ryu YS, Piao MJ, Shilnikova K,
Kang HK, Yi JM, Boulanger M, Paolillo R, Bossis G, Yoon SY, et al:
DUOX2-mediated production of reactive oxygen species induces
epithelial mesenchymal transition in 5-fluorouracil resistant human
colon cancer cells. Redox Biol. 17:224–235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Meng Q, Shi S, Liang C, Liang D, Hua J,
Zhang B, Xu J and Yu X: Abrogation of glutathione peroxidase-1
drives EMT and chemoresistance in pancreatic cancer by activating
ROS-mediated Akt/GSK3β/Snail signaling. Oncogene. 37:5843–5857.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jiao L, Li DD, Yang CL, Peng RQ, Guo YQ,
Zhang XS and Zhu XF: Reactive oxygen species mediate
oxaliplatin-induced epithelial-mesenchymal transition and invasive
potential in colon cancer. Tumour Biol. 37:8413–8423. 2016.
View Article : Google Scholar : PubMed/NCBI
|
